Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07636382
What this trial is testing

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain

Who this might be right for
Advanced CancerPancreatic Cancer
University Health Network, Toronto 5
Early research (Phase 1)Active Not RecruitingNCT02495896
What this trial is testing

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more
University of Southern California 61
Testing effectiveness (Phase 2)Study completedNCT02905578
What this trial is testing

Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)

Who this might be right for
Pancreatic NeoplasmsCancer of PancreasCancer of the Pancreas+4 more
University of Iowa 40
Not applicableUnknownNCT02817308
What this trial is testing

Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas

Who this might be right for
Carcinoma, Pancreatic Ductal
Rambam Health Care Campus 100
Not applicableStudy completedNCT02347618
What this trial is testing

Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdenocarcinoma
University of Rochester 18
Testing effectiveness (Phase 2)Study completedNCT00390182
What this trial is testing

Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC)

Who this might be right for
Gastrointestinal NeoplasmsOvarian Neoplasms
University of Maryland, Baltimore 38
Testing effectiveness (Phase 2)Looking for participantsNCT05257993
What this trial is testing

Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Onconic Therapeutics Inc. 71
Early research (Phase 1)Looking for participantsNCT06821048
What this trial is testing

Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerStomach CancerPancreatic Cancer+1 more
Weijia Fang, MD 18
Testing effectiveness (Phase 2)Ended earlyNCT03300843
What this trial is testing

Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer

Who this might be right for
MelanomaGastrointestinal CancerBreast Cancer+2 more
National Cancer Institute (NCI) 1
Not applicableLooking for participantsNCT06549725
What this trial is testing

Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening

Who this might be right for
Pancreas CancerPancreatic Ductal AdenocarcinomaHereditary Diseases+1 more
Lipidica, a.s. 419
Testing effectiveness (Phase 2)Study completedNCT00268840
What this trial is testing

The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer

Who this might be right for
Pancreatic NeoplasmsBiliary Tract Neoplasms
ARCAGY/ GINECO GROUP 45
Early research (Phase 1)Ended earlyNCT03520790
What this trial is testing

Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Dana-Farber Cancer Institute 36
Not applicableStudy completedNCT00937079
What this trial is testing

Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients

Who this might be right for
HyperinsulinismHypoglycemiaInsulinoma
University Hospital, Basel, Switzerland 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03600233
What this trial is testing

Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsPancreatic Neuroendocrine TumorGastro-enteropancreatic Neuroendocrine Tumor+2 more
TaiRx, Inc. 34
Early research (Phase 1)Study completedNCT02050178
What this trial is testing

Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer

Who this might be right for
Pancreatic CancerStage IV Pancreatic Cancer
OncoMed Pharmaceuticals, Inc. 26
Not applicableUnknownNCT05495685
What this trial is testing

IDentification and vAlidation Model of Liquid biopsY Based cfDNA Methylation and pRotEin biomArKers for Pancreatic Cancer (DAYBREAK Study)

Who this might be right for
Cancer
Changhai Hospital 450
Not applicableLooking for participantsNCT06705335
What this trial is testing

Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma

Who this might be right for
Pancreas Cancer
Institut Bergonié 50
Testing effectiveness (Phase 2)Study completedNCT02551991
What this trial is testing

Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Ipsen 56
Testing effectiveness (Phase 2)Study completedNCT02243358
What this trial is testing

Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreas Neoplasm Malignant Resectable
Henry Ford Health System 24
Testing effectiveness (Phase 2)Study completedNCT02151448
What this trial is testing

ΑDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies

Who this might be right for
Malignant Neoplasm of Pancreas Metastatic to Peritoneal SurfaceMalignant Peritoneal MesotheliomaPeritoneal Carcinomatosis
David Bartlett 64
Next Page